FIELD: pharmaceutical industry.
SUBSTANCE: invention relates to the pharmaceutical industry, namely to a composition for the treatment of chronic osteomyelitis. Composition for the treatment of chronic osteomyelitis, including a semi-synthetic antibiotic amikacin sulfate, taken from the calculation of the maximum allowable daily dose of 15 mg/kg, calcium hydroxyapatite in the form of a powder with a particle size of 50-150 microns in the amount necessary to completely fill the bone cavity, which additionally includes powdered deer antlers with a particle size of 100-150 microns; the ratio of amikacin sulfate and deer antlers is 2:1; the required volume of the composition is calculated individually based on the results of radiation diagnostics of the volume of the bone cavity.
EFFECT: composition quickly stops inflammation and ensures the formation of bone tissue in the area of the defect, effectively for the treatment of chronic osteomyelitis.
1 cl, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| POWDER PHARMACEUTICAL FORM FOR RELIEF ACCELERATION OF OSTEOMYELITIS CONTAINING CHLORIDE RUBIDIUM | 2018 |
|
RU2668692C1 |
| METHOD FOR TREATING THE CASES OF RECIDIVATING OSTEOMYELITIS OF LONG BONES BY ADMINISTERING COLLAPAN | 1998 |
|
RU2155552C2 |
| METHOD OF TREATING CHRONIC OSTEOMYELITIS | 2023 |
|
RU2811281C1 |
| METHOD OF THE TREATMENT OF CHRONIC POST-TRAUMATIC OSTEOMYELITIS | 2022 |
|
RU2800318C1 |
| METHOD FOR TREATMENT OF PATIENTS SUFFERING FROM CHRONIC OSTEOMYELITIS | 1992 |
|
RU2073514C1 |
| METHOD OF PREPARING FILLING MASS FOR CLOSURE OF BONE DEFECT | 2017 |
|
RU2676478C1 |
| METHOD FOR SURGICAL TREATMENT OF CHRONIC OSTEOMYELITIS | 2001 |
|
RU2209595C2 |
| METHOD OF TREATING CHRONIC OSTEOMYELITIS OF LONG BONES | 2013 |
|
RU2544303C1 |
| METHOD OF BONE DEFECT CLOSURE | 2017 |
|
RU2644828C1 |
| METHOD OF REPLACING BONE DEFECTS AND ELECTRET IMPLANT FOR ITS IMPLEMENTATION | 2021 |
|
RU2810013C2 |
